FEMY vs TECH
Femasys Inc (FEMY) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Femasys Inc (FEMY) is a medical instruments & supplies company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported FEMY revenue for 2024-12-31 was $1.6M. Net income was -$18.8M. Revenue was up 52.0% from 2023-12-31 to 2024-12-31. FEMY currently screens at market cap $925.2K.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
FEMY currently screens at market cap $925.2K. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the FEMY and TECH stock pages for the full models.
Not investment advice.